Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Eppendorf and DASGIP introduce the first single-use mini bioreactor for parallel bioprocessing

20.06.2012
At this year’s Achema, held from June 18 – 22 in Frankfurt/Main, Eppendorf and the DASGIP Information and Process Technology GmbH, a leading manufacturer of Parallel Bioreactor Systems and comprehensive software solutions for bioprocessing, will show for the first time the new single-use mini bioreactor DASbox single-use vessel.

The development of the DASbox single-use vessel reinforces the strong synergy that benefits both DASGIP and the Eppendorf AG, which acquired the bioprocessing specialist this past January. “Within a very short time we were able to combine the long-standing competency of the Eppendorf AG in the field of plastics technology with our bioreactor expertise, which led to a new product”, explains Dr. Matthias Arnold, member of DASGIP management and head of the development department.

The DASbox single-use vessel is the first single-use bioreactor which was developed for the DASGIP Parallel Bioreactor Systems. As a fully instrumented mini bioreactor with a working volume of 60-250 ml, it was constructed specifically for use in combination with the DASGIP DASbox mini bioreactor system. Especially with cell culture users in mind, the advantages of singleuse technology are combined with the benefits of parallel cultivation and the full functionality of industrial bioreactors. All critical process parameters such as pH, soluble oxygen and optical density can be monitored and controlled using industry standard probes.

Integrated dip tubes allow for controlled addition of liquids, sampling, as well as fully massflow controlled gas supply. The magnet coupled stirrer is only one of the examples for the uncompromising sterile technology of this single-use bioreactor. A special feature of the DASbox single-use vessel is the novel, liquid-free Peltier element temperature control and condensation. This innovation, which enables, amongst others, efficient liquid condensation from the exhaust air, represents a further milestone in the transfer of the requirements of classic bioreactor technology to single-use technology.

The DASbox single-use vessel accelerates bioprocess development. The small working volumes save precious cell material and media, and extensive cleaning and sterilization procedures are superfluous. Less time is required for installation of the bioreactor, and cross contaminations are virtually excluded. Parallel cultivation under precisely controlled conditions delivers reliable results, fast. Further, the comprehensive software functions of DASGIP DASware allow user friendly and detailed capture, saving, analysis and management of resulting data.

We look forward to meeting you at the Achema at our booths:

Eppendorf hall 4.2. booth G7
DASGIP hall 4.2. booth L15
About Eppendorf:
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Associated consumables like pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the instruments for highest quality workflow solutions. Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance. Eppendorf was founded in Hamburg, Germany in 1945 and has about 2,600 employees worldwide. The company has subsidiaries in 23 countries and is represented in all other markets by distributors.
Additional information can be found at: http://www.eppendorf.com
Contact: Dr. Oliver Franz, Phone: +49 40 53 801 801, franz.o@eppendorf.de
About DASGIP:
DASGIP DASGIP has been an industry-leading supplier of benchtop bioreactor solutions for the biotech, pharmaceutical and chemical industries as well as academia and research institutions, since 1991. Process engineers, scientists and product developers use DASGIP Parallel Bioreactor Systems and software solutions for the cultivation of microbial, plant, animal and human cells to benefit from increased productivity, high reproducibility, and ease of scale-up. A team of more than 70 in-house experts contribute to the ongoing success of the company with a compound 5 years annual growth rate of about 25%. DASGIP is headquartered in Juelich (Germany) and has operations throughout Europe, North America and Asia. In January 2012, DASGIP was acquired by Eppendorf AG, premium manufacturers of liquid, sample and cell handling products and expert partners in life science laboratories.
Additional information is available at: http://www.dasgip.com
Contact: Claudia M. Hüther-Franken, Phone: +49 2461 980 119, c.huether@dasgip.de

Christiane Niehues-Pröbsting | DASGIP
Further information:
http://www.eppendorf.com
http://www.dasgip.com

More articles from Trade Fair News:

nachricht Hannover Messe 2018: Cognitive system for predictive acoustic maintenance
19.04.2018 | Fraunhofer-Institut für Digitale Medientechnologie IDMT

nachricht ILA 2018: Cost-effective carbon fibers for light-weight construction
18.04.2018 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Trade Fair News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>